Tag: GlaxoSmithKline
GSK Acquires Sierra For $1.9B
GlaxoSmithKline is acquiring California biopharmaceutical firm Sierra Oncology for $1.9 billion in a deal expected to help both companies take a major step in developing a treatment for rare...
GlaxoSmithKline & Pfizer Are Holding Out For Higher Bid In Joint...
GlaxoSmithKline (GSK) and Pfizer are holding out for an improved bid of at least £60 billion (US$82 billion) for their consumer healthcare joint venture,...
Saudi Chemical In $27M GlaxoSmithKline Deal
Saudi Chemical Company Holding (SCCH) has struck a deal with GlaxoSmithKline to make pharmaceutical products in the Kingdom.SCCH unit AJA Pharmaceutical Industries will team...
Paroxetine – The EU Court of Justice Rules on Pay-For-Delay Settlements...
Maria José Schmidt-Kessen (Copenhagen Business School)1
Introduction
While we are still awaiting the judgments in the pending appeals on pay-for-delay settlements in Lundbeck2 and Servier,3 the...
EU: EC approves GlaxoSmithKline’s acquisition of Pfizer’s Consumer Health Business
The European Commission has approved, under the EU Merger Regulation, the acquisition of Pfizer's Consumer Health Business by GlaxoSmithKline. The decision is conditional upon...
UK: GlaxoSmithKline agrees to buy Tesaro for $4.5bn
Tesaro shares surged 58% Monday after GlaxoSmithKlineagreed to buy the cancer treatment company for $75 per share, or about $5.1 billion.
The deal represents a...
Australia: Regulator to take GSK, Novartis to court
Australia’s competition watchdog is to take local units of GlaxoSmithKline and Novartis to court over alleged false or misleading marketing of pain relief gels.
The...
